Showing results (1-10 of 74) with videos related to
Sort By:
Pageof 8
International Journal of Technology Assessment in Health Care|December 3, 2013
Approaches to identifying, measuring, and aggregating elements of valueAdrian Towse, Paul BarnsleyHealth Affairs (Project Hope)|May 22, 2003
The efficient use of pharmaceuticals: does Europe have any lessons for a Medicare drug benefit?Adrian TowseHealth Economics|June 28, 2007
If it ain't broke, don't price fix it: the OFT and the PPRSAdrian TowseBritish Journal of Clinical Pharmacology|August 19, 2010
Value based pricing, research and development, and patient access schemes. Will the United Kingdom get it right or wrong?Adrian TowsePharmacoeconomics|November 30, 2002
National Institute for Clinical Excellence (NICE): Is economic appraisal working?Adrian Towse, Clive PritchardValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2019
Uncertainty and Cures: Discontinuation, Irreversibility, and Outcomes-Based Payments: What Is Different About a One-Off Treatment?Adrian Towse, Elisabeth FenwickValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 14, 2024
It Takes 2 to Tango. Setting Out the Conditions in Which Performance-Based Risk-Sharing Arrangements Work for Both PartiesAdrian Towse, Elisabeth FenwickValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 5, 2002
The economics of gene therapy and of pharmacogeneticsPatricia Danzon, Adrian TowseThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 18, 2014
Orphan drugs policies: a suitable case for treatmentMichael Drummond, Adrian TowseFrontiers in Health Services|March 17, 2023
The cost-per-QALY threshold in England: Identifying structural uncertainty in the estimatesBernarda Zamora, Adrian TowsePageof 8